Network meta-analysis evaluates efficacy and safety of inhaled levodopa doses in Parkinson’s disease, suggesting optimal approaches for managing OFF episodes.
To evaluate and compare the efficacy and safety of different doses of inhaled levodopa (CVT-301) for the management of OFF episodes in patients with Parkinson’s disease using a network meta-analysis.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: